Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemiaRuibin Zhang, Yong‐Ouk You, Z-D Zhong et al.|Bone Marrow Transplantation|2017Cited by 29